These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6359581)

  • 1. [Ovarian irridation and prednisone versus tamoxifen (Nolvadex) in advanced breast cancer].
    Gundersen S; Kvaløy S; Fosså SD; Høst H
    Tidsskr Nor Laegeforen; 1983 Sep; 103(27):1873-5. PubMed ID: 6359581
    [No Abstract]   [Full Text] [Related]  

  • 2. The management of locally advanced carcinoma of the breast by Nolvadex (tamoxifen): a pilot study.
    Campbell FC; Morgan DA; Bishop HM; Benton FM; Blamey RW; Elston CW; Nicholson RI; Griffiths K
    Clin Oncol; 1984 Jun; 10(2):111-5. PubMed ID: 6734002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian ablation as treatment for young women with breast cancer.
    Davidson NE
    J Natl Cancer Inst Monogr; 1994; (16):95-9. PubMed ID: 7528032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.
    Meakin JW; Allt WE; Beale FA; Bush RS; Clark RM; Fitzpatrick PJ; Hawkins NV; Jenkin RD; Pringle JF; Reid JG; Rider WD; Hayward JL; Bulbrook RD
    Eur J Cancer (1965); 1980; Suppl 1():179-81. PubMed ID: 7032930
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant breast cancer therapies improve survival, worldwide analysis shows.
    Oncology (Williston Park); 1992 Jun; 6(6):19, 21-2. PubMed ID: 1535208
    [No Abstract]   [Full Text] [Related]  

  • 6. Tamoxifen in breast cancer.
    Drug Ther Bull; 1986 Aug; 24(17):65-7. PubMed ID: 3757793
    [No Abstract]   [Full Text] [Related]  

  • 7. Ovarian ablation as adjuvant therapy for early-stage breast cancer.
    Pritchard KI
    Cancer Treat Res; 1998; 94():158-80. PubMed ID: 9587687
    [No Abstract]   [Full Text] [Related]  

  • 8. Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients.
    Cohen I; Figer A; Tepper R; Shapira J; Altaras MM; Yigael D; Beyth Y
    Gynecol Oncol; 1999 Feb; 72(2):202-7. PubMed ID: 10021302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal manipulation in the adjuvant treatment of breast cancer.
    Honig SF; Swain SM
    Important Adv Oncol; 1993; ():103-23. PubMed ID: 8505047
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.
    Mouridsen HT; Salimtschik M; Dombernowsky P; Gelshoj K; Palshof T; Rorth M; Daehnfeldt JL; Rose C
    Eur J Cancer (1965); 1980; Suppl 1():107-10. PubMed ID: 7032918
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
    Cavalli F; Alberto P; Jungi F; Brunner K; Martz G
    Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922
    [No Abstract]   [Full Text] [Related]  

  • 12. DES versus tamoxifen in advanced breast cancer.
    N Engl J Med; 1981 Apr; 304(17):1041-3. PubMed ID: 7010171
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: a decision analysis.
    Punglia RS; Kuntz KM; Lee JH; Recht A
    J Clin Oncol; 2003 Jun; 21(12):2260-7. PubMed ID: 12805324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Christie Hospital tamoxifen (Nolvadex) adjuvant trial for operable breast carcinoma--7-yr results.
    Ribeiro G; Swindell R
    Eur J Cancer Clin Oncol; 1985 Aug; 21(8):897-900. PubMed ID: 3899666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the role of ovarian ablation in the management of primary and metastatic breast cancer today?
    Prowell TM; Davidson NE
    Oncologist; 2004; 9(5):507-17. PubMed ID: 15477635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant treatment for breast cancer in the elderly.
    Marchei P; Bianco V; Pignatelli E; Chiodini S; Santini D; Carico E; Marchei M; Vecchione A
    Anticancer Res; 1996; 16(2):911-3. PubMed ID: 8687150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast carcinoma--adjuvant chemo- and hormone therapy].
    Fey MF
    Ther Umsch; 1998 Jul; 55(7):413-4. PubMed ID: 9702106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen and breast cancer--from palliation to prevention.
    Rich SE
    Cancer Nurs; 1993 Oct; 16(5):341-6. PubMed ID: 7505194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of post-chemotherapy tamoxifen in early breast cancer.
    Tolcher AW
    Oncology (Williston Park); 1994 Nov; 8(11):39-43; discussion 47-9. PubMed ID: 7826838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anastrozole: licence extension. No advantage over tamoxifen in advanced-stage breast cancer.
    Prescrire Int; 2001 Jun; 10(53):76-7. PubMed ID: 11718168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.